Literature DB >> 10600131

Anophelin: kinetics and mechanism of thrombin inhibition.

I M Francischetti1, J G Valenzuela, J M Ribeiro.   

Abstract

Anophelin is a 6.5-kDa peptide isolated from the salivary gland of Anopheles albimanus that behaves as an alpha-thrombin inhibitor. In this paper, kinetic analyses and the study of mechanism of alpha-thrombin inhibition by anophelin were performed. Anophelin was determined to be a reversible, slow, tight-binding inhibitor of alpha-thrombin, displaying a competitive type of inhibition. The binding of anophelin to alpha-thrombin is stoichiometric with a dissociation constant (K(i)) of 5.87 +/- 1.46 pM, a calculated association rate constant (k(1)) of 2.11 +/- 0.06 x 10(8) M(-1) s(-1), and a dissociation rate constant (k(-1)) of 4.05 +/- 0.97 x 10(-4) s(-1). In the presence of 0.15 and 0.4 M NaCl, a 17.6- and 207-fold increase in the K(i) of anophelin-alpha-thrombin complex was observed, respectively, indicating that ionic interactions are important in anophelin-alpha-thrombin complex formation. Incubation of alpha-thrombin with C-terminal hirudin fragment 54-65 that binds to alpha-thrombin anion binding exosite 1 (TABE1) attenuates alpha-thrombin inhibition by anophelin; anophelin also blocks TABE1-dependent trypsin-mediated proteolysis of alpha-thrombin. Using gamma-thrombin, an alpha-thrombin derivative where the anion binding exosite has been disrupted, anophelin behaves as a fast and classical competitive inhibitor of gamma-thrombin hydrolysis of small chromogenic substrate (K(i) = 0. 694 +/- 0.063 nM). In addition, anophelin-gamma-thrombin complex formation is prevented by treatment of the enzyme with D-Phe-Pro-Arg-chloromethyl ketone (PPACK), a reagent that irreversibly blocks the catalytic site of thrombin. It is concluded that anophelin is a potent dual inhibitor of alpha-thrombin because it binds both to TABE1 and to the catalytic site, optimal binding being dependent on the availability of both domains. Finally, anophelin inhibits clot-bound alpha-thrombin with an IC(50) of 45 nM and increases the lag phase that precedes explosive in vitro alpha-thrombin generation after activation of intrinsic pathway of blood coagulation. Because of its unique primary sequence, anophelin may be used as a novel reagent to study the structure and function of alpha-thrombin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10600131     DOI: 10.1021/bi991231p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  37 in total

Review 1.  An insight into the sialome of blood-feeding Nematocera.

Authors:  José M C Ribeiro; Ben J Mans; Bruno Arcà
Journal:  Insect Biochem Mol Biol       Date:  2010-08-20       Impact factor: 4.714

2.  Counteracting effect of glycyrrhizin on the hemostatic abnormalities induced by Bothrops jararaca snake venom.

Authors:  Mariane Assafim; Marcos S Ferreira; Flávia S Frattani; Jorge A Guimarães; Robson Q Monteiro; Russolina B Zingali
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

3.  Ixolaris: a factor Xa heparin-binding exosite inhibitor.

Authors:  Robson Q Monteiro; Alireza R Rezaie; José M C Ribeiro; Ivo M B Francischetti
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

4.  Aegyptin displays high-affinity for the von Willebrand factor binding site (RGQOGVMGF) in collagen and inhibits carotid thrombus formation in vivo.

Authors:  Eric Calvo; Fuyuki Tokumasu; Daniella M Mizurini; Peter McPhie; David L Narum; José Marcos C Ribeiro; Robson Q Monteiro; Ivo M B Francischetti
Journal:  FEBS J       Date:  2009-12-15       Impact factor: 5.542

5.  Neither mosquito saliva nor immunity to saliva has a detectable effect on the infectivity of Plasmodium sporozoites injected into mice.

Authors:  Chahnaz Kebaier; Tatiana Voza; Jerome Vanderberg
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

6.  Alboserpin, a factor Xa inhibitor from the mosquito vector of yellow fever, binds heparin and membrane phospholipids and exhibits antithrombotic activity.

Authors:  Eric Calvo; Daniella M Mizurini; Anderson Sá-Nunes; José M C Ribeiro; John F Andersen; Ben J Mans; Robson Q Monteiro; Michail Kotsyfakis; Ivo M B Francischetti
Journal:  J Biol Chem       Date:  2011-06-14       Impact factor: 5.157

7.  Unique thrombin inhibition mechanism by anophelin, an anticoagulant from the malaria vector.

Authors:  Ana C Figueiredo; Daniele de Sanctis; Ricardo Gutiérrez-Gallego; Tatiana B Cereija; Sandra Macedo-Ribeiro; Pablo Fuentes-Prior; Pedro José Barbosa Pereira
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-05       Impact factor: 11.205

Review 8.  Challenges and approaches for mosquito targeted malaria control.

Authors:  José L Ramirez; Lindsey S Garver; George Dimopoulos
Journal:  Curr Mol Med       Date:  2009-03       Impact factor: 2.222

9.  An insight into the sialotranscriptome of the West Nile mosquito vector, Culex tarsalis.

Authors:  Eric Calvo; Irma Sanchez-Vargas; Amanda J Favreau; Kent D Barbian; Van M Pham; Kenneth E Olson; José Mc Ribeiro
Journal:  BMC Genomics       Date:  2010-01-20       Impact factor: 3.969

10.  The salivary gland transcriptome of the neotropical malaria vector Anopheles darlingi reveals accelerated evolution of genes relevant to hematophagy.

Authors:  Eric Calvo; Van M Pham; Osvaldo Marinotti; John F Andersen; José M C Ribeiro
Journal:  BMC Genomics       Date:  2009-01-29       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.